ADDRESS: Street, City, Country
PHONE: +(123) 456 789
E-MAIL: your-email@mail.com
The Haryana Pharma and Medical Devices Manufacturing Policy 2026 aims to attract INR 10,000 crore in investments and generate 20,000 jobs over the next five years.
dineshwori
FUJIFILM’s AMULET SOPHINITY platform combines advanced AI-enabled technologies, high-definition imaging capabilities, and ergonomically designed patient-centric features.
imphoenix82
The newly appointed Drug Inspectors are authorized to exercise the powers and perform the duties as specified in Sections 21 and 22 of the Drugs and Cosmetics Act and the Medical Devices Rules.
imphoenix82
The FDA’s approval of bemotrizinol marks the first addition of a new active ingredient to the OTC sunscreen monograph in more than two decades.
imphoenix82
As part of Eli Lilly’s new national campaign, O’Neal is sharing his personal experience with moderate-to-severe obstructive sleep apnea, including his diagnosis and treatment journey with Zepbound (tirzepatide).
imphoenix82
The global AI in healthcare market is projected to grow from USD 20.2 billion in 2025 to USD 146.3 billion by 2031, according to a new report by Wissen Research.
dineshwori
California-based NeuroRester Corp. has unveiled Wearable 2.0, a new wellness ecosystem designed to move beyond simple health tracking and provide users with personalized support for relaxation and recovery. The ecosystem is built around the company’s proprietary NAP (Nightly-Active Protocol) technology and includes two flagship devices: NeuroRester, an earbud-style wearable that uses Bioboosti technology to promote […]
imphoenix82
Carestream’s new X-ray detectors are equipped with DEC technology for wireless mode, allowing more precise and efficient dose control during imaging procedures.
imphoenix82
Robot-assisted prostate biopsy technologies, such as the Biobot Mona Lisa, are emerging as a promising solution for improving the detection of clinically significant prostate cancer. Read more …
dineshwori
Therapeutic innovation in chronic pain: VERTANICAL’s Exilby has shown superior pain reduction and better gastrointestinal tolerability than opioids in Phase 3 study.
imphoenix82HealthXplore is a digital platform dedicated to delivering insights into what’s new and what’s next in healthcare, pharmaceuticals, and medical innovation. We aim to bridge the gap between complex industry developments and informed audiences by presenting credible, timely, and engaging content.
Contact: +91 8447496924
HealthXploreIndia @2026. All Rights Reserved.
